We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Deep Learning Software Assists in Detection of Aortic Atherosclerosis and Aortic Ectasia on Chest X-Rays

By HospiMedica International staff writers
Posted on 08 Dec 2022

A new, FDA cleared computer-assisted detection (CADe) device assists physicians at detecting findings on chest X-rays that are suggestive of Aortic Atherosclerosis and Aortic Ectasia. More...

Aorta-CAD is a cloud-based, software-only medical device that uses deep learning to detect and highlight findings associated with Aortic Atherosclerosis and Aortic Ectasia. The device is part of Imagen Technologies’ (New York, NY, USA) Diagnostics as a Service (DaaS) platform. It can assist any physician who reads chest X-rays, including radiologists and Primary Care Physicians (PCPs). Aorta-CAD identifies findings on the chest X-ray image and creates annotations that draw attention to those findings via an overlay. The overlay can be toggled off when not being used by the physician. It seamlessly integrates into existing X-ray reading workflows without the need for new PACS technology or costly re-training of physicians.

With assistance from Aorta-CAD, physicians are better equipped to diagnose and start treating Aortic Atherosclerosis and Aortic Ectasia earlier. Aorta-CAD presents an opportunity for practices to identify these previously undiagnosed chronic ailments, improve quality of life for their patients, and reduce total cost of care. Like other components of Imagen's platform, Aorta-CAD delivers significant results for patients, physicians, and the health care system.

"Imagen is on a mission to help Primary Care Physicians deliver faster, better diagnoses and care plans. By expanding our diagnostics as a service platform with Aorta-CAD, we expect to help PCPs significantly improve the quality of care and clinical outcomes for their patients with undiagnosed Aortic Atherosclerosis and Aortic Ectasia," said Alex Dresner, CEO at Imagen Technologies.

"Aorta-CAD assists the physician to have a consistent and repeatable process to look into the cardiac silhouette providing additional information to enhance the patient's treatment plans and care," said Scott Howell, Imagen's Chief Medical Officer.

Related Links:
Imagen Technologies


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.